Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human SIGLEC8 Stable Cell Line

    [CAT#: S01YF-1023-PY206]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Immune Checkpoint Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Immune Checkpoint
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;BV2
    Target Classification
    Immune Checkpoint Cell Lines
    Target Research Area
    Digestive and Renal Research
    Related Diseases
    Eosinophilic Gastritis; Indolent Systemic Mastocytosis
    Gene ID
    Human:27181
    UniProt ID
    Human:Q9NYZ4

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    SIGLEC8 is a lectin found in immune cells that plays a regulatory role by recognizing self-associated glycans and inhibiting immune cell functions. It has a high degree of specificity for sialyl N-acetyllactosamine (sLacNAc) with specific sulfations. The sequence variety in the CC' loop of SIGLEC8, SIGLEC9, and SIGLEC3 determines their recognition of sulfated oligosaccharides. SIGLEC8 has been studied as a potential therapeutic target for mast cell-mediated diseases, such as urticaria. Mast cell silencing, achieved through the engagement of inhibitory receptors like SIGLEC8, is a novel therapeutic approach for these diseases. In addition, SIGLEC8 has been identified as a hub gene in psoriasis, suggesting its potential as a diagnostic biomarker and therapeutic target. Furthermore, SIGLEC8 and other Siglecs have been explored as potential targets for therapy in mast cell- and eosinophil-associated diseases. Lirentelimab, a monoclonal antibody against SIGLEC8, has been investigated in a clinical trial for refractory indolent systemic mastocytosis and has shown safety, tolerability, and efficacy in reducing symptoms. Overall, SIGLEC8 has diverse applications in understanding disease mechanisms, developing diagnostic biomarkers, and exploring therapeutic interventions.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human SIGLEC8 Stable Cell Line (S01YF-1023-PY206). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Jordan Smith (Verified Customer)

    How does SIGLEC8 interact with its ligands? Dec 22 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The interaction of SIGLEC8 with its ligands, such as sialylated oligosaccharides, is being explored for potential therapeutic applications. Dec 22 2022

    chat Skyler Smith (Verified Customer)

    What is the significance of SIGLEC8 gene polymorphisms in asthma? Nov 17 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Polymorphisms in the SIGLEC8 gene have been associated with asthma in various populations, indicating its potential role in the disease's pathogenesis. Nov 17 2020

    Published Data

    Fig.1 An elevation in cellular uptake of monomeric Aβ1-42 is facilitated by the heightened expression of Siglec-8.

    The quantification of relative mean fluorescence intensities (MFI) for the uptake of monomeric Aβ between empty vector and Siglec-expressing populations was conducted. Relative values were determined for each mouse and human Siglec construct, and the data were presented as bars indicating the mean ± 95% CI, with a sample size of 6 replicates. Statistical significance was assessed using an unpaired Student's t-test, two-sided, with *P < 5e-2, **P < 1e-2, ***P < 1e-3, and ****P < 1e-4 denoting significance levels, while "ns" denoted non-significance. The mean of the 2xY->F group was represented by a dotted line.

    Ref: Morshed, Nader, et al. "Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration." Molecular Systems Biology 16.12 (2020): e9819.

    Pubmed: 33289969

    DOI: 10.15252/msb.20209819

    Research Highlights

    Wang, Yucheng. et al. "Sequence variety in the CC' loop of Siglec-8/9/3 determines the recognitions to sulfated oligosaccharides." Computational and structural biotechnology journal, 2023.
    Siglecs play a vital role in immune regulation by recognizing self-associated glycans and converting extracellular interactions into signals that inhibit immune cell functions. While various Siglecs have been identified to display broad specificities towards different types of sulfated oligosaccharides, recent research has revealed that Siglec-8 and Siglec-9 exhibit a high degree of specificity for sialyl 6-sulfo sugars. These findings highlight the significance of specific binding interactions between Siglecs and their target glycans in modulating immune responses.
    Wang, Yucheng. et al. "Sequence variety in the CC' loop of Siglec-8/9/3 determines the recognitions to sulfated oligosaccharides." Computational and structural biotechnology journal, 2023.
    Pubmed: 37675287   DOI: 10.1016/j.csbj.2023.08.014

    Mesnil, Claire et al. "Lung-resident eosinophils represent a distinct regulatory eosinophil subset." The Journal of clinical investigation vol. 126,9 (2016): 3279-95.
    Elevated eosinophil levels are commonly associated with infections and allergic conditions, such as asthma. However, there is also evidence suggesting that eosinophils play a role in maintaining immune balance. Recent research has characterized resident eosinophils (rEos) in the lungs of mice, revealing them as IL-5-independent Siglec-FintCD62L+CD101lo cells with a unique ring-shaped nucleus. During house dust mite-induced airway allergies, rEos remained unchanged and were accompanied by recruited inflammatory eosinophils (iEos), which were IL-5-dependent Siglec-FhiCD62L-CD101hi cells with segmented nuclei. Gene expression analysis indicated that rEos had a more regulatory profile than iEos. Mice lacking lung rEos displayed heightened Th2 cell responses to inhaled allergens, attributed to rEos' ability to inhibit the maturation of allergen-loaded DCs. Interestingly, similar phenotypic distinctions were observed between human lung rEos and iEos from eosinophilic asthmatic patients, suggesting the relevance of these findings to humans and underscoring the essential role of lung rEos in maintaining homeostasis.
    Mesnil, Claire et al. "Lung-resident eosinophils represent a distinct regulatory eosinophil subset." The Journal of clinical investigation vol. 126,9 (2016): 3279-95.
    Pubmed: 27548519   DOI: 10.1172/JCI85664

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare